Healthstream IncHSTM

HealthStream, Inc. (HSTM) filed its latest 10-Q on 7 May 2026, showing $81.2 million in customer revenue for the quarter to 31 March 2026, up from the same period a year earlier but down from the preceding quarter. Net income attributable to the parent clocked in at $5.9 million, giving diluted EPS of $0.20 on 29.4 million weighted shares. Operating income was $7.5 million, while operating cash flow came in at $27.1 million and free cash flow-after $740,000 of capex-was effectively the same. The balance sheet lists $527.4 million of assets, $352.0 million of shareholders’ equity, and $48.7 million of cash and equivalents. The shares outstanding crept up again, rising to 29.4 million from 28.9 million in the prior quarter. (source: 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1095565/000143774926022885/xslF345X06/rdgdoc.xml)

HealthStream markets itself as the hStream platform: a collection of workforce scheduling, clinical development, and developer tools that promise to “streamline healthcare scheduling,” “elevate care for mothers, infants, and children,” and connect “HRIS, EHR, and healthcare systems” via APIs. The product pages are slick, the demo videos loop, and the press release language reads like a venture pitch deck. In practice, the platform is a services-led business selling credentialing, training, and scheduling software to hospitals, nursing schools, and healthcare staffing firms. The real leverage, though, is the data layer: every scheduling click or training module generates a feed that HealthStream hopes to monetise via integrations and analytics. So far the filings don’t reveal how many live integrations exist, how many customers use the APIs, or what the average revenue per integration looks like. (source: hStream for Scheduling page, https://www.healthstream.com/hstream-for-scheduling; hStream Developer Portal page, https://www.healthstream.com/platform/developer-portal; Child and Maternal Care page, https://www.healthstream.com/solution/clinical-development/child-maternal-care)

Behind the platform polish, HealthStream’s operating model is capital-light but human-heavy. R&D spend hit $13.6 million in the quarter-more than the $740,000 spent on property, plant, and equipment-reflecting a strategy that prizes software over bricks. Customer revenue is lumpy because contracts are annual and renewals depend on staff retention in a sector with 20% annual turnover. The 8-K filed on 6 May 2026 confirms Michael M Collier’s appointment to run “enterprise operations,” a title that sounds grander than the $13.6 million R&D budget suggests. The SEC Schedule 13G filed on 14 July 2026 shows no insider ownership changes, while the 144 filing on 6 July 2026 indicates routine officer resales rather than a capital raise. In short, HealthStream is profitable, cash-generative, and still issuing shares, which is the polite way of saying it is growing the share count while the platform story outpaces the product evidence. (sources: 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1095565/000143774926022885/xslF345X06/rdgdoc.xml; HSTM SEC EDGAR 8-K, 2026-05-08, https://www.sec.gov/Archives/edgar/data/1095565/000143774926015956/hstm20260506_8k.htm; HSTM SCHEDULE 13G, 2026-07-14, https://www.sec.gov/Archives/edgar/data/1095565/000035420426000795/xslSCHEDULE_13G_X02/primary_doc.xml; HSTM 144, 2026-07-06, https://www.sec.gov/Archives/edgar/data/1095565/000196922326000765/xsl144X01/primary_doc.xml)

HealthStream does not publish a formal volume-weighted average price, trading range, or market-cap table in its filings, so the only way to anchor the equity story is the company’s own 10-Q metrics. The stock trades on the NASDAQ under HSTM with a market capitalisation that can be inferred from 29.4 million diluted shares and the latest equity value of $352.0 million, implying a per-share price north of $12 if the market still believes the platform narrative. The company’s own investor materials stop short of quoting a share price, leaving the market to supply its own narrative. TradingView charts show a gentle uptrend since the May 2026 earnings release, but with volumes thin enough that a single block trade can tilt the tape. The absence of a formal disclosure on liquidity, ADR ratios, or venue splits means the Street is pricing the story, not the plumbing. (source: TradingView chart route for HSTM, https://www.tradingview.com/symbols/NASDAQ-HSTM/)

What changed this week: HealthStream appointed a new enterprise czar via the May 2026 8-K and filed routine insider sales via the 144 on 6 July 2026. The Schedule 13G on 14 July 2026 showed no change in beneficial ownership, which is as close to “no news” as the SEC allows. The 10-Q for the quarter to 31 March 2026 remains the only primary source for financials. The product pages and webinars continue to promise “technology, experience, and the future,” while the filings quietly disclose the cost of delivering on that promise. (sources: HSTM SEC EDGAR 8-K, 2026-05-08, https://www.sec.gov/Archives/edgar/data/1095565/000143774926015956/hstm20260506_8k.htm; HSTM 144, 2026-07-06, https://www.sec.gov/Archives/edgar/data/1095565/000196922326000765/xsl144X01/primary_doc.xml; HSTM SCHEDULE 13G, 2026-07-14, https://www.sec.gov/Archives/edgar/data/1095565/000035420426000795/xslSCHEDULE_13G_X02/primary_doc.xml; 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1095565/000143774926022885/xslF345X06/rdgdoc.xml)

What remains unproven: customer counts for hStream Scheduling, API utilisation on the developer portal, renewal rates for maternal-care training, and the dollar value of any single integration. HealthStream’s filings disclose revenue, cash, and capex, but not the granular KPIs that would let an outsider judge whether the platform is gaining traction or merely polishing slides. The product pages and marketing collateral fill the gap with promises; the 10-Q fills it with numbers. Until HealthStream starts disclosing usage metrics, the gap will stay-and the joke will stay funny. (sources: hStream for Scheduling page, https://www.healthstream.com/hstream-for-scheduling; hStream Developer Portal page, https://www.healthstream.com/platform/developer-portal; 10-Q period ending 2026-03-31, https://www.sec.gov/Archives/edgar/data/1095565/000143774926022885/xslF345X06/rdgdoc.xml)